Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of$0.29. This compares to a loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +13.79$0.29 per share when it actually produced a loss of $0.33, delivering a surprise of -13.79%.Over the last four quarters ...